From: Homeopathic drug proving of Okoubaka aubrevillei: a randomised placebo-controlled trial
Placebo (n = 11) | Okoubaka (n = 18) | |
---|---|---|
Sociodemographic characteristics | ||
Age (± standard deviation) | 41.1 (± 8.9) | 33.9 (± 8.5) |
Female (%) | 8 (73) | 11 (61) |
Medical doctors (%) | 10 (91) | 13 (72) |
Medical students (%) | 0 (0) | 5 (28) |
Disease history | ||
Past chronic disease (%) | 6 (54) | 9 (50) |
Present chronic disease (%) | 7 (64) | 12 (67) |
Experiences | ||
Experiences in participation in past HDP (%) | 2 (18) | 3 (16) |
Estimation of sensitivity to homeopathic drugs | ||
Sensitive or highly sensitive | ||
• Subjects’ estimation (%) | 11 (100) | 10 (55) |
• Investigators’ estimation (%) | 10 (91) | 15 (73) |
Expectation about reaction to homeopathic drug | ||
Observation of very high numbers / many symptoms | ||
• Subjects’ estimation (%) | 4 (36) | 2 (11) |
• Investigators’ estimation (%) | 9 (82) | 10 (56) |